EWM
ORKA

Empirical Wealth Management’s Oruka Therapeutics ORKA Stock Holding History

Empirical Wealth Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Buy
19,312
+1,083
+6% +$72.2K 0.03% 286
2026
Q1 		$894K Buy
18,229
+2,823
+18% +$98.1K 0.02% 381
2025
Q4 		$467K Hold
15,406
– – 0.01% 540
2025
Q3 		$296K Buy
+15,406
New +$228K 0.01% 618

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Empirical Wealth Management's ORKA Position: Q2 2026 in Review

Empirical Wealth Management increased its Oruka Therapeutics (ORKA) stake by 5.9% in Q2 2026, buying an estimated $72.2K and bringing the position to 19,312 shares worth $1.84M. The position accounts for 0.03% of the portfolio, ranked #286.

Empirical Wealth Management first reported a position in ORKA in Q3 2025 and has held it in 4 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Empirical Wealth Management held 19,312 shares of Oruka Therapeutics worth $1.84M as of Q2 2026.
  • Empirical Wealth Management bought 1,083 Oruka Therapeutics shares in Q2 2026, an estimated $72.2K.
  • Oruka Therapeutics made up 0.03% of Empirical Wealth Management's portfolio in Q2 2026, its #286 holding.
  • Empirical Wealth Management first reported a position in Oruka Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.